Strengths and weaknesses of long-term bioassays-Reference-Cited by-同舟云学术

Strengths and weaknesses of long-term bioassays

Published:1987-03 Issue:1 Volume:7 Page:113-119
ISSN:0273-2300
Container-title:Regulatory Toxicology and Pharmacology
language:en
Short-container-title:Regulatory Toxicology and Pharmacology

Author:

Schach von Wittenau M.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference16 articles.

1. Is phenobarbital carcinogenic?;Clemmesen;Ecotoxicol. Environ. Saf.,1978

2. Carcinogenesis bioassay data: Correlation by species and sex;DiCarlo;Drug Metab. Rev.,1984

3. Summary of carcinogenicity data generated by the National Cancer Institute/National Toxicology Program;DiCarlo;Drug Metab. Rev.,1984

4. Issues in carcinogenicity testing: Dose selection;Haseman;Fundam. Appl. Toxicol.,1985

5. Proceedings of a Symposium Sponsored by the National Center for Toxicological Research, U.S. Food and Drug Administration, and The American College of Toxicology;Innovations in Cancer Risk Assessment (ED01study),1979

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Historical perspective on risk assessment in the federal government;Toxicology;1995-09

2. The practice of health risk assessment in the united states (1975–1995): How the U.S. and other countries can benefit from that experience;Human and Ecological Risk Assessment: An International Journal;1995-03

3. The Rodent Carcinogenicity Bioassay Produces a Similar Frequency of Tumor Increases and Decreases: Implications for Risk Assessment;Regulatory Toxicology and Pharmacology;1994-12

4. Pharmacokinetic data in the evaluation of the safety of food and color additives;Regulatory Toxicology and Pharmacology;1992-02

5. Important recent advances in the practice of health risk assessment: Implications for the 1990s;Regulatory Toxicology and Pharmacology;1989-12